Cell Biotech Co., Ltd. (KOSDAQ:049960)
14,070
+110 (0.79%)
At close: Mar 6, 2026
5.24% (1Y)
| Market Cap | 93.08B |
| Revenue (ttm) | 50.65B |
| Net Income (ttm) | 12.59B |
| Shares Out | 6.84M |
| EPS (ttm) | 1,839.56 |
| PE Ratio | 7.39 |
| Forward PE | n/a |
| Dividend | 450.00 (3.20%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 15,454 |
| Average Volume | 40,067 |
| Open | 14,060 |
| Previous Close | 13,960 |
| Day's Range | 13,790 - 14,080 |
| 52-Week Range | 11,350 - 15,950 |
| Beta | 0.36 |
| RSI | 46.89 |
| Earnings Date | Feb 13, 2026 |